Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Zygomycosis.

M G Rinaldi1

  • 1Fungus Testing Laboratory, Department of Pathology, University of Texas Health Science Center San Antonio.

Infectious Disease Clinics of North America
|March 1, 1989
PubMed
Summary
This summary is machine-generated.

Zygomycosis is a severe fungal infection affecting immunocompromised individuals. Early diagnosis and treatment with amphotericin B improve outcomes, but new diagnostic tools and antifungals are needed.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correlation of susceptibility of Cryptococcus neoformans to amphotericin B with clinical outcome.

Antimicrobial agents and chemotherapy·2011
Same author

Molecular and phenotypic characterization of Phialemonium and Lecythophora isolates from clinical samples.

Journal of clinical microbiology·2011
Same author

Spectrum of clinically relevant Acremonium species in the United States.

Journal of clinical microbiology·2010
Same author

Molecular phylogeny and proposal of two new species of the emerging pathogenic fungus Saksenaea.

Journal of clinical microbiology·2010
Same author

Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document).

Journal of clinical microbiology·2010
Same author

Comparison of 24-hour and 48-hour voriconazole MICs as determined by the Clinical and Laboratory Standards Institute broth microdilution method (M27-A3 document) in three laboratories: results obtained with 2,162 clinical isolates of Candida spp. and other yeasts.

Journal of clinical microbiology·2009
Same journal

Prevention and Control of Clostridioides difficile Infection for the Infectious Diseases Clinician.

Infectious disease clinics of North America·2026
Same journal

Infection Control Strategies to Prevent Emergence and Transmission of Resistant Gram-Negative Bacteria.

Infectious disease clinics of North America·2026
Same journal

Preventing the Spread of Tuberculosis in Health Care Settings.

Infectious disease clinics of North America·2026
Same journal

Threats to Success: Principles of Infection Prevention and Control in Health Care Settings, Part 2: Device and Pathogen Management.

Infectious disease clinics of North America·2026
Same journal

Ventilator-Associated Events: Surveillance and Prevention.

Infectious disease clinics of North America·2026
Same journal

Nosocomial Fungal Infections: Epidemiology, Control Strategies, and Prevention of Candida and Other Yeasts.

Infectious disease clinics of North America·2026
See all related articles

Area of Science:

  • Mycology
  • Infectious Diseases
  • Immunology

Background:

  • Zygomycosis is an opportunistic fungal infection.
  • It primarily affects debilitated, immunocompromised, or acidotic hosts.
  • Infections are often fulminant, causing vascular invasion, infarction, and necrosis.

Purpose of the Study:

  • To review the current understanding of zygomycosis.
  • To highlight advancements in its management.
  • To identify areas for future research.

Main Methods:

  • Literature review of zygomycosis cases and treatments.
  • Analysis of epidemiological trends and causative agents.
  • Evaluation of diagnostic and therapeutic strategies.

Related Experiment Videos

Main Results:

  • The spectrum of causative agents and incidence of zygomycosis have increased.
  • Aggressive surgical debridement and amphotericin B therapy improve prognosis.
  • Despite improvements, zygomycosis remains a life-threatening condition.

Conclusions:

  • Increased index of suspicion and improved mycological acumen are crucial.
  • Prompt treatment with amphotericin B is vital.
  • Development of rapid diagnostics and less toxic antifungals is essential for enhanced management.